Literature DB >> 20665004

Serum cytokines and critical illness-related corticosteroid insufficiency.

Yong Soo Kwon1, Gee Young Suh, Kyeongman Jeon, So Young Park, So Yeon Lim, Won-Jung Koh, Man Pyo Chung, Hojoong Kim, O Jung Kwon.   

Abstract

PURPOSE: Little information exists regarding the association of specific cytokine levels and different subgroups of patients with critical illness-related corticosteroid insufficiency (CIRCI).
METHODS: Data from a previous prospective study on adrenal function in the ICU were used in this study. CIRCI was diagnosed when either the basal cortisol was less than 10 μg/ml or the Δ cortisol was less than 9 μg/ml. The patients with CIRCI were further divided into a low basal cortisol (LBC) group (basal cortisol < 10 μg/ml), and low Δ cortisol (LDC) group (basal cortisol ≥ 10 μg/ml and Δ cortisol < 9 μg/ml). Serum cytokine levels were compared among the normal (NOM), LBC, and LDC groups.
RESULTS: The serum of 82 out of 123 (67%) patients included in the previous study was available for analysis; these patients were included in the present study. The overall incidence of CIRCI was 43.9% (36 out of 82 patients). Among patients with CIRCI, 16 (44.4%) were classified as the LBC group and 20 (55.6%) as the LDC group. The LDC group had significantly higher levels of IL-6 and IL-10 compared to both the NOM and LBC groups (p < 0.01). The LDC group also had significantly increased TNF-α (p = 0.002) compared to the LBC group. There were no significant differences in any of the cytokine levels between the NOM and LBC groups.
CONCLUSIONS: Elevated cytokines were associated with adrenal dysfunction in a subset of patients meeting the criteria for CIRCI (normal or high basal cortisol and low Δ cortisol).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20665004     DOI: 10.1007/s00134-010-1971-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs.

Authors:  S R Bornstein; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

2.  Monocytes stimulate cortisol production by cultured human adrenocortical cells.

Authors:  R W Whitcomb; W M Linehan; L M Wahl; R A Knazek
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

3.  Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery.

Authors:  Erich Kilger; Florian Weis; Josef Briegel; Lorenz Frey; Alwin E Goetz; Daniel Reuter; Andreas Nagy; Albert Schuetz; Peter Lamm; Anette Knoll; Klaus Peter
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Acute adrenal insufficiency in the burn intensive care unit.

Authors:  R L Sheridan; C M Ryan; R G Tompkins
Journal:  Burns       Date:  1993-02       Impact factor: 2.744

Review 5.  IL-10 as a mediator in the HPA axis and brain.

Authors:  E M Smith; P Cadet; G B Stefano; M R Opp; T K Hughes
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

6.  Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells.

Authors:  M Jäättelä; V Ilvesmäki; R Voutilainen; U H Stenman; E Saksela
Journal:  Endocrinology       Date:  1991-01       Impact factor: 4.736

7.  Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.

Authors:  A Soni; G M Pepper; P M Wyrwinski; N E Ramirez; R Simon; T Pina; H Gruenspan; C E Vaca
Journal:  Am J Med       Date:  1995-03       Impact factor: 4.965

8.  Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.

Authors:  Ioanna Dimopoulou; Stylianos Tsagarakis; Andreas T Kouyialis; Paraskevi Roussou; Georgios Assithianakis; Marietta Christoforaki; Ioannis Ilias; Damianos E Sakas; Nikolaos Thalassinos; Charis Roussos
Journal:  Crit Care Med       Date:  2004-02       Impact factor: 7.598

9.  Cortisol levels in patients with severe community-acquired pneumonia.

Authors:  Jorge I F Salluh; Juan C Verdeal; Gustavo W Mello; Leonardo V Araújo; Gloria A R Martins; Marcelo de Sousa Santino; Márcio Soares
Journal:  Intensive Care Med       Date:  2006-01-28       Impact factor: 17.440

10.  Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.

Authors:  Rainer H Straub; Georg Pongratz; Jürgen Schölmerich; Frieder Kees; Thomas F Schaible; Christian Antoni; Joachim R Kalden; Hanns-Martin Lorenz
Journal:  Arthritis Rheum       Date:  2003-06
View more
  9 in total

1.  The "koala stress syndrome" and adrenal responsiveness in the critically ill.

Authors:  Paul E Marik; Alexander Levitov
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

2.  Etomidate increases susceptibility to pneumonia in trauma patients.

Authors:  Karim Asehnoune; Pierre Joachim Mahe; Philippe Seguin; Samir Jaber; Boris Jung; Christophe Guitton; Nolwen Chatel-Josse; Aurelie Subileau; Anne Charlotte Tellier; Françoise Masson; Benoit Renard; Yannick Malledant; Corinne Lejus; Christelle Volteau; Véronique Sébille; Antoine Roquilly
Journal:  Intensive Care Med       Date:  2012-07-10       Impact factor: 17.440

3.  The effects of three specific conditions related to critical care on adrenal function in children.

Authors:  Gülay Karagüzel; Süleyman Atay; Orhan Değer; Mustafa İmamoğlu; Ayşenur Ökten; Güngör Karagüzel
Journal:  Intensive Care Med       Date:  2012-08-10       Impact factor: 17.440

4.  Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentals.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-01-04       Impact factor: 17.440

5.  A new way of thinking: hydrocortisone in traumatic brain-injured patients.

Authors:  Antoine Roquilly; Mickael Vourc'h; Raphael Cinotti; Karim Asehnoune
Journal:  Crit Care       Date:  2013-12-04       Impact factor: 9.097

Review 6.  Early prevention of trauma-related infection/sepsis.

Authors:  Xiao-Yuan Ma; Li-Xing Tian; Hua-Ping Liang
Journal:  Mil Med Res       Date:  2016-11-08

Review 7.  Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19.

Authors:  Chiara Sabbadin; Corrado Betterle; Carla Scaroni; Filippo Ceccato
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-24       Impact factor: 5.555

8.  Stress-dose hydrocortisone reduces critical illness-related corticosteroid insufficiency associated with severe traumatic brain injury in rats.

Authors:  Xin Chen; Zilong Zhao; Yan Chai; Lanlan Luo; Rongcai Jiang; Jingfei Dong; Jianning Zhang
Journal:  Crit Care       Date:  2013-10-16       Impact factor: 9.097

Review 9.  What we have to know about corticosteroids use during Sars-Cov-2 infection.

Authors:  F Ferraù; F Ceccato; S Cannavò; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.